Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
- Posted on February 10, 2025
- By CNBC
- 2 Views
![](https://image.cnbcfm.com/api/v1/image/108096275-1738586589508-gettyimages-2196133108-AFP_36WR46H.jpeg?v=1738599443&w=1920&h=1080)
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
![](https://image.cnbcfm.com/api/v1/image/108096275-1738586589508-gettyimages-2196133108-AFP_36WR46H.jpeg?v=1738599443&w=1920&h=1080)
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.